Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis to Participate in Upcoming Investor Conferences

Tuesday, August 8, 2023 1 min read
Key Takeaway: Enovis Corporation (NYSE: ENOV) announced that its management team will participate in two upcoming investor conferences. The Canaccord Genuity 43rd Annual Growth Conference is scheduled for August 9th in Boston, while the Baird 2023 Global Healthcare Conference will take place on September 12th in New York. The company's leadership, including CFO Ben Berry, will represent Enovis during these events, showcasing the company's commitment to innovation in medical technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is actively engaging with investors at multiple conferences.
  • The company's focus on innovation in medical technology demonstrates commitment to growth.
  • Participation in prominent investor events can enhance visibility and attract more investment.

Full Press Release Details

Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
Canaccord Genuity 43rd Annual Growth Conference: On Wednesday, August 9th, Ben Berry, Chief Financial Officer, will be meeting with investors at the conference which is scheduled to take place in Boston, MA.
Baird 2023 Global Healthcare Conference: On Tuesday, September 12th, Ben Berry, Chief Financial Officer, and Brady Shirley, Chief Operating Officer, will be meeting with investors at the conference, which is scheduled to take place in New York, NY.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Vice President, Investor Relations
investorrelations@enovis.com
Source: Enovis Corporation

Frequently Asked Questions

When will Enovis participate in the Canaccord conference?

Enovis will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 9th.

Which conferences will Enovis attend in 2023?

Enovis will attend the Canaccord and Baird Global Healthcare Conferences.

Who will represent Enovis at the Baird conference?

Ben Berry and Brady Shirley will represent Enovis at the Baird conference.

What does Enovis Corporation focus on?

Enovis focuses on developing clinically differentiated solutions for better patient outcomes.

What is the stock symbol for Enovis Corporation?

The stock symbol for Enovis Corporation is ENOV, listed on NYSE.

Tags: ENOV Viatris Investor Conferences Healthcare Enovis investor conferences medical technology Boston
Last updated: Aug 8, 2023